3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
Specimen Handling
3
Blood Specimen Collection
3
Surveys and Questionnaires
2
Standard of Care
2
Practice Guidelines as Topic
2
COVID-19 Vaccines
2
COH04S1 COVID-19 vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sotrovimab
1
ciclesonide
1
Therapeutics
1
Telemedicine
1
Sodium Chloride
1
Patient Reported Outcome Measures
1
Observation
1
Nutritional Status
1
Niclosamide
1
IMM-101
1
Exercise Therapy
1
Exercise
1
Educational Status
1
Diagnostic Tests, Routine
1
Data Collection
1
CVnCoV COVID-19 vaccine
1
BNT162 Vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
COVID-19
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
NCT05831787
2026-05-18
COSMIC
ASH Research Collaborative
Completed
201 enrolled
15 charts